Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Hemagglutinin 1 (HA1)

Hemagglutinin 1 (HA1)

Brief Information

Name:Minor Histocompatibility Protein HA-1
Target Synonym:Rho GTPase Activating Protein 45,HLA-HA1,HA-1,Histocompatibility (Minor) HA-1,HMHA1,Minor Histocompatibility Antigen HA-1,KIAA0223,ARHGAP45
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

 Hemagglutinin 1 (HA1) SPR

Monoclonal Anti-Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] HA1 Antibody, Human IgG1 (8A1) (Cat. No. HA1-M694) captured on Protein A Chip can bind Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] HA1 Protein, His Tag (Cat. No. HA1-V52H5) with an affinity constant of 2.10 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

 Hemagglutinin 1 (HA1) ELISA

Immobilized Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin 1 (HA1) Protein, His Tag (Cat. No. HA1-V52H5) at 1 μg/mL (100 μL/well) can bind Anti-HA Monoclonal Antibody (H9N2) with a linear range of 0.1-4 ng/mL (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
TSC-100 TSC-100 Phase 1 Clinical TScan Therapeutics Inc Hematologic Neoplasms; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message